While research is ongoing, a landmark 2022 study including more than 2,500 adults with obesity or overweight and one weight-related medical condition found that participants lost an average of 20.9% of their body weight over the course of 72 weeks, or about 16.5 months
With the goal of providing relief and improving the quality of life for those affected by this condition, scientists are exploring various avenues of research
Gut microbial carbohydrate metabolism contributes to insulin resistance
Tirzepatide is a synthetic peptide that is rapidly degraded by digestive enzymes within the gastrointestinal tract, Dr
manufacturers often offer significant discounts for bulk purchases of finished soap
Novo Nordisk) were FDA approved in 2014 and 2021, respectively, to treat obesity